The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: ondansetron     Quarter: 2016Q3

Total Records: 1,451     Number of Pages: 73

DRUGNAME PT EventCount
ONDANSETRONE RANBAXY Congenital anomaly 1
ONDANSETRONE RANBAXY Foetal exposure during pregnancy 1
ONDANSETRONE RANBAXY Gastrooesophageal reflux disease 1
ONDANSETRONE RANBAXY Hyperkalaemia 1
ONDANSETRONE RANBAXY Intervertebral disc degeneration 1
ONDANSETRONE RANBAXY Laryngomalacia 1
ONDANSETRONE RANBAXY Maternal exposure during pregnancy 1
ONDANSETRONE RANBAXY Micrognathia 1
ONDANSETRONE RANBAXY Multiple congenital abnormalities 1
ONDANSETRONE RANBAXY Overweight 1
ONDANSETRONE RANBAXY Pierre Robin syndrome 1
ONDANSETRONE RANBAXY Product use issue 1
ONDANSETRONE RANBAXY Renal failure 1
ONDANSETRONE RANBAXY Renal hypertension 1
ONDANSETRONE TEVA Anhedonia 1
ONDANSETRONE TEVA Atrial septal defect 1
ONDANSETRONE TEVA Cardiomegaly 1
ONDANSETRONE TEVA Cardiopulmonary failure 1
ONDANSETRONE TEVA Deformity 1
ONDANSETRONE TEVA Ebstein's anomaly 1

Total Records: 1,451     Number of Pages: 73